Developing effective antitoxins poses several challenges, including identifying the most potent immunogenic epitopes, ensuring the safety and efficacy of the antitoxin, and overcoming regulatory hurdles. Additionally, the cost of production and limited shelf life of some antitoxins can impact their accessibility and availability.
